In Vivo Evaluation of Pam2Cys‐Modified Cancer‐Testis Antigens as Potential Self‐Adjuvanting Cancer Vaccines
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Peptide Science"
DOI: 10.1002/psc.70022
Abstract: Peptide‐based vaccines, formulated with an appropriate adjuvant, offer a versatile platform for targeted cancer immunotherapy. While adjuvants are usually coadministered for nucleic acid and protein vaccines, synthetic peptide antigens afford a more effective opportunity to… read more here.
Keywords: cancer; testis antigens; self adjuvanting; pam2cys ... See more keywords